State Street’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$276K Hold
69,252
﹤0.01% 3812
2025
Q4
$276K Buy
69,252
+3,400
+5% +$12.6K ﹤0.01% 3821
2025
Q3
$207K Hold
65,852
﹤0.01% 3906
2025
Q2
$312K Buy
65,852
+6,000
+10% +$28.1K ﹤0.01% 3722
2025
Q1
$283K Hold
59,852
﹤0.01% 3744
2024
Q4
$414K Buy
59,852
+2,700
+5% +$19.8K ﹤0.01% 3664
2024
Q3
$331K Hold
57,152
﹤0.01% 3682
2024
Q2
$305K Buy
57,152
+14,400
+34% +$66.2K ﹤0.01% 3693
2024
Q1
$162K Hold
42,752
﹤0.01% 3920
2023
Q4
$101K Hold
42,752
﹤0.01% 4056
2023
Q3
$118K Hold
42,752
﹤0.01% 4073
2023
Q2
$135K Hold
42,752
﹤0.01% 4131
2023
Q1
$223K Hold
42,752
﹤0.01% 4041
2022
Q4
$317K Hold
42,752
﹤0.01% 3928
2022
Q3
$536K Sell
42,752
-3,300
-7% -$39.4K ﹤0.01% 3752
2022
Q2
$354K Hold
46,052
﹤0.01% 3973
2022
Q1
$466K Buy
46,052
+3,765
+9% +$34.4K ﹤0.01% 4079
2021
Q4
$305K Buy
42,287
+31,700
+299% +$174K ﹤0.01% 4181
2021
Q3
$38K Buy
+10,587
New +$38.7K ﹤0.01% 4659

Other funds holding SRTS

State Street's SRTS Position: Q1 2026 in Review

State Street held its Sensus Healthcare (SRTS) position steady in Q1 2026 at 69,252 shares worth $276K. The position accounts for ﹤0.01% of the portfolio, ranked #3812.

State Street first reported a position in SRTS in Q3 2021 and has held it in 19 quarters since. The position peaked at $536K in Q3 2022. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.

  • State Street held 69,252 shares of Sensus Healthcare worth $276K as of Q1 2026.
  • State Street left its Sensus Healthcare share count unchanged in Q1 2026.
  • Sensus Healthcare made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3812 holding.
  • State Street first reported a position in Sensus Healthcare in Q3 2021 and has held it in 19 quarters since.
  • State Street's Sensus Healthcare position peaked at $536K in Q3 2022.
  • 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.